Point-of-Need 2020 – Including PCR-Based Testing

Yole Développement

COVID-19 is shaking up the diagnostics industry and will have both short- and long-term impact.

What’s new

  • In addition to the usual segmentation by application/ settings, this year we introduce the expected segmentation and market data/forecasts per type of test, spanning immunoassay, molecular diagnostics, clinical chemistry and more
  • Detailed data for over 50 players, presented through charts: Installed base of instruments, instruments placed per year, tests per instrument per year, test ASP per type of test, consumable pullthrough per instrument
  • More depth on market shares, per segment, and detailed list of players per segment
  • Examples of success stories and failures, companies to watch in the coming years, and key considerations for commercial success
  • New detailed sub-segmentation for the veterinary market and for the emergency testing market

Key features

  • Overview of what microfluidic technology offers to point-of-need (PoN) testing
  • New major trends and evolution at the market level and at the technology level including a focus on the high-plex molecular diagnostics space, and a focus on multi-modal platforms
  • Updated market data and forecast 2018-2025, in value and units for microfluidic devices and tests, per segment and per type of test
  • Supply chain description and analysis
  • Market segmentation with technical and economical requirements per segment, product examples, key players, market share, and market and technology trends

Liked this post?

Share it on your social networks